A vaccine for COVID-19 which uses cutting-edge RNA technology has entered phase 1 clinical trials. If successful, it could revolutionise the future of vaccine development.
The COVID-19 outbreak is not just a public health crisis, it’s rapidly becoming a global crisis – of health, economics and politics.
As the outbreak of COVID-19 continues to spread in China and countries around the world, a global community of researchers are working to find out more about the virus and assess what research needs to be done to stop it.
Wellcome is making a pledge of up to £10 million to accelerate research and support global efforts to tackle the ongoing coronavirus (COVID-19) epidemic.
Discovering and then bringing new antibiotics to market is a tricky challenge – but one we need to solve if we want to be better protected against the growing threat of drug-resistant infections. Here’s why, and what has to happen to develop new medicines.
The commitment to research during the last two Ebola outbreaks has changed the course of this disease. Jeremy Farrar reflects on what made this possible.
The licensing of the first Ebola vaccine is a great achievement for the global healthcare community. What made it possible, and what lessons can we use to prevent and control future outbreaks?
It's a year since the Ebola outbreak in the Democratic Republic of the Congo began. If we want to prevent future outbreaks lasting a year, the world needs to address research gaps.